| Psoriasis |
1 |
1 |
| Lipids Management |
0 |
0.83 |
| Statins |
0 |
0.62 |
| New York |
0 |
0.48 |
| Cardiovascular Risk Management |
0 |
0.99 |
| Cardiovascular disease |
0 |
0.98 |
| Grant |
0 |
0.28 |
| Risk Management |
0 |
0.28 |
| Blood |
0 |
0.21 |
| Pennsylvania |
0 |
0.21 |
| Hypertension |
0 |
0.18 |
| Cardiometabolic Risk Factors |
0 |
0.16 |
| Clinical Guidelines |
0 |
0.14 |
| Multiple Sclerosis |
0 |
0.1 |
| Clinical Research |
0 |
0.07 |
| Diet |
0 |
0.07 |
| Dyslipidemia |
0 |
0.07 |
| Exercise |
0 |
0.07 |
| Health Education and Counseling |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Hyperlipidemia |
0 |
0.07 |
| Preventive Screening |
0 |
0.07 |
| Primary Care |
0 |
0.07 |
| Traction |
0 |
0.07 |
| Biologic Therapy |
0 |
0.05 |
| Obesity |
0 |
0.05 |
| Telehealth and Telemedicine |
0 |
0.05 |